专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06413983B1 Benzopyranyl heterocycle derivatives, process for preparation thereof, and pharmaceutical compositions containing them 失效
标题翻译：苯并吡喃基杂环衍生物，其制备方法和含有它们的药物组合物
公开(公告)号：US06413983B1
公开(公告)日：2002-07-02
申请号：US09724029
申请日：2000-11-28
申请人： Sung-Eun Yoo , Sun Kyung Lee , Kyu Yang Yi , Nak Jeong Kim , Jee Hee Suh , Hwa Sup Shin , Byung Ho Lee , Ho Won Seo , Hong Lim , Sun-Ok Kim , Dongha Lee , Insun Cho , Miae Namgung , Dongsoo Jang
发明人： Sung-Eun Yoo , Sun Kyung Lee , Kyu Yang Yi , Nak Jeong Kim , Jee Hee Suh , Hwa Sup Shin , Byung Ho Lee , Ho Won Seo , Hong Lim , Sun-Ok Kim , Dongha Lee , Insun Cho , Miae Namgung , Dongsoo Jang
IPC分类号： A01N4342
CPC分类号： C07D498/14 , C07D405/04
摘要： The present invention relates to novel benzopyranyl heterocycle derivatives of the formula 1, process for preparation thereof and pharmaceutical use of the benzopyranyl heterocycle derivatives. The benzopyranyl heterocycle derivatives of the present invention can be used for protecting heart, brain, retina and neuronal cell from “ischemia-reperfusion” injury, treatment for diseases related to it and suppressing lipid peroxidation. Wherein R1, R2, R3, R4, n and * are each defined in specification.
摘要翻译：本发明涉及式1的新型苯并吡喃基杂环衍生物，其制备方法和苯并吡喃基杂环衍生物的药物用途。本发明的苯并吡喃基杂环衍生物可用于保护心脏，脑，视网膜和神经元细胞免受“缺血再灌注”损伤，治疗与之相关的疾病和抑制脂质过氧化作用。其中R1，R2，R3，R4，n 和*各自在规范中定义。

2. 发明授权

US06323238B1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them 失效
标题翻译：苯并吡喃基胍衍生物，其制备方法和含有它们的药物组合物
公开(公告)号：US06323238B1
公开(公告)日：2001-11-27
申请号：US09693082
申请日：2000-10-20
申请人： Sung-Eun Yoo , Kyu Yang Yi , Sun Kyung Lee , Nak-Jeong Kim , Jee Hee Suh , Young Sook Park , Sun Kyung Hwang , Hwa Sup Shin , Byung Ho Lee , Ho Won Seo , Hong Lim , Sun-Ok Kim , In Sun Cho , Miae Namgoong , Dongsoo Jang
发明人： Sung-Eun Yoo , Kyu Yang Yi , Sun Kyung Lee , Nak-Jeong Kim , Jee Hee Suh , Young Sook Park , Sun Kyung Hwang , Hwa Sup Shin , Byung Ho Lee , Ho Won Seo , Hong Lim , Sun-Ok Kim , In Sun Cho , Miae Namgoong , Dongsoo Jang
IPC分类号： C07D31174
CPC分类号： C07D407/04 , A61K31/155 , A61K31/352 , C07D311/68
摘要： The present invention relates to novel benzopyranyl guanidine derivatives of the formula 1, process for preparation therof and pharmaceutical use of the benzopyranyl guanidine derivatives. The benzopyranyl guanidine derivatives of the present invention can be used for protecting heart, neuronal cell or brain damage, preserving organs, and also the benzopyranyl guanidine derivatives are pharmacologically useful for inhibiting NO generation, and for suppressing lipid peroxidation, angiogenesis or restenosis. Wherein R1, R2, R3, R4, R5, R6, n and * are each defined in specification.
摘要翻译：本发明涉及式1的新型苯并吡喃基胍衍生物，其制备方法和苯并吡喃基胍衍生物的药物用途。本发明的苯并吡喃基胍衍生物可用于保护心脏，神经元细胞或脑损伤，保存器官，苯并吡喃基胍衍生物在药理学上可用于抑制NO产生，抑制脂质过氧化，血管生成或再狭窄。其中R1 ，R2，R3，R4，R5，R6，n和*各自在说明书中定义。

3. 发明授权

US07420060B2 Benzopyran derivatives substituted with a thioxobenzoxazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them 失效
标题翻译：被噻吩并恶唑衍生物取代的苯并吡喃衍生物，其药学上可接受的盐，它们的制剂和含有它们的药物组合物
公开(公告)号：US07420060B2
公开(公告)日：2008-09-02
申请号：US10558111
申请日：2004-05-28
申请人： Hong Lim , Dong Ha Lee , Sun Ok Kim , Sung-Eun Yoo , Kyu Yang Yi , Sun Kyung Lee , Jee Hee Suh , Nak Jeong Kim , Sun Kyung Hwang , Tae Mi Kim , Byung Ho Lee , Ho-Won Seo
发明人： Hong Lim , Dong Ha Lee , Sun Ok Kim , Sung-Eun Yoo , Kyu Yang Yi , Sun Kyung Lee , Jee Hee Suh , Nak Jeong Kim , Sun Kyung Hwang , Tae Mi Kim , Byung Ho Lee , Ho-Won Seo
IPC分类号： C07D263/58
CPC分类号： C07D413/04
摘要： The present invention relates to benzopyran derivatives substituted with a thioxobenzoxazole derivative, or pharmaceutically acceptable salts thereof, processes for preparing the same and a pharmaceutical composition containing the above as an effective ingredient Benzopyran derivatives substituted with thioxobenzoxazole derivatives, represented in , have the function of protecting heart from ischemia-reperfusion both in vivo and in vitro, so that a pharmaceutical composition containing benzopyran derivatives substituted with thioxobenzoxoazole derivatives or pharmaceutically acceptable salts thereof of the present invention as an effective ingredient can be effectively used for the protection of tissues influenced by ischemia-reperfusion, for example, for the protection of heart, nervous cells, brain, retinal cells, storage organs, etc, and for the treatment of diseases caused by ischemia-reperfusion.
摘要翻译：本发明涉及用硫代苯并恶唑衍生物取代的苯并吡喃衍生物或其药学上可接受的盐，其制备方法和含有上述作为有效成分的药物组合物用<式1>所示的噻吩并恶唑衍生物取代的苯并吡喃衍生物具有在体内和体外保护心脏免于缺血 - 再灌注的功能，使得含有本发明的噻唑并苯并恶唑衍生物或其可药用盐取代的苯并吡喃衍生物的药物组合物作为有效成分可以有效地用于保护组织受缺血再灌注的影响，例如保护心脏，神经细胞，脑，视网膜细胞，储存器官等，以及治疗由局部缺血 - 再灌注引起的疾病。

4. 发明授权

US07309793B2 Benzopyran derivatives substituted with a benzimidazole derivative, pharmaceutically acceptable salts therof, their preparations and pharmaceutical compositions containing them 失效
标题翻译：被苯并咪唑衍生物取代的苯并吡喃衍生物，其药学上可接受的盐，其制剂和含有它们的药物组合物
公开(公告)号：US07309793B2
公开(公告)日：2007-12-18
申请号：US10558020
申请日：2004-05-28
申请人： Hong Lim , Dong Ha Lee , Sun Ok Kim , Sung-Eun Yoo , Kyu Yang Yi , Sun Kyung Lee , Jee Hee Suh , Nak Jeong Kim , Sun Kyung Hwang , Tae Mi Kim , Byung Ho Lee , Ho-Won Seo
发明人： Hong Lim , Dong Ha Lee , Sun Ok Kim , Sung-Eun Yoo , Kyu Yang Yi , Sun Kyung Lee , Jee Hee Suh , Nak Jeong Kim , Sun Kyung Hwang , Tae Mi Kim , Byung Ho Lee , Ho-Won Seo
IPC分类号： C07D235/26 , C07D235/28 , C07D235/30
CPC分类号： C07D405/04 , C07D405/14
摘要： The present invention relates to benzopyran derivatives substituted with a benzimidazole derivative, or pharmaceutically acceptable salts thereof, a preparation method of the same and pharmarceutical compositions containing them. Benzopyran derivatives substituted with a benzimidazole derivative, represented in Formula (1), have the function of protecting heart from ischemia-reperfusion without side effect like vasodilation, so that a pharmaceutical composition containing benzopyran derivatives substituted with a benzimidazole derivative or pharmaceutically acceptable salts thereof of the present invention as an effective ingredient can be effectively used for the protection of tissues influenced by ischemia-reperfusion, for example, for the protection of heart, nervous cells, brain, retinal cells, storage organs, etc. and for the treatment of diseases caused by ischemia-reperfusion.
摘要翻译：本发明涉及用苯并咪唑衍生物取代的苯并吡喃衍生物或其药学上可接受的盐，其制备方法和含有它们的药物组合物。由式（1）表示的苯并咪唑衍生物取代的苯并吡喃衍生物具有保护心脏免于缺血再灌注而无副作用如血管舒张的功能，因此含有苯并咪唑衍生物或其药学上可接受的盐取代的苯并吡喃衍生物的药物组合物作为有效成分的本发明可以有效地用于保护受缺血再灌注影响的组织，例如用于保护心脏，神经细胞，脑，视网膜细胞，储存器官等，并用于治疗疾病由缺血再灌注引起。

5. 发明授权

US07351843B2 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them 失效
标题翻译：呋喃羰基胍衍生物，其制备方法和含有它们的药物组合物
公开(公告)号：US07351843B2
公开(公告)日：2008-04-01
申请号：US10581799
申请日：2004-12-24
申请人： Kyu Yang Yi , Sun Kyung Lee , Nak Jeong Kim , Jee Hee Suh , Soon Hee Hwang , Byung Ho Lee , Ho Won Seo , Sun Kyung Hwang , Sung Eun Yoo , Kyung Hee Lee
发明人： Kyu Yang Yi , Sun Kyung Lee , Nak Jeong Kim , Jee Hee Suh , Soon Hee Hwang , Byung Ho Lee , Ho Won Seo , Sun Kyung Hwang , Sung Eun Yoo , Kyung Hee Lee
IPC分类号： C07D307/02 , A61K31/34 , A01N43/08
CPC分类号： C07D307/68
摘要： The present invention relates to furancarbonylguanidine derivatives, a preparation method thereof and a pharmaceutical composition comprising the same.Furancarbonylguanidine derivatives of the present invention inhibit NHE-1 (sodium-hydrogen exchanger isoform 1), which helps recovery of heart function damaged from ischemia/reperfusion and decreases myocardial infarction rate, indicating that they have protective effect on myocardial cells. Thus, furancarbonylguanidine derivatives of the present invention can be effectively used for the prevention and the treatment of ischemic heart diseases such as myocardial infarction, arrhythmia, angina pectoris, etc, and also a promising candidate for a heart protecting agent applied to reperfusion therapy including thrombolytics or cardiac surgery including coronary artery bypass graft, percutaneous transluminal coronary angioplasty, etc.
摘要翻译：本发明涉及呋喃羰基胍衍生物，其制备方法和包含其的药物组合物。本发明的呋喃羰基胍衍生物抑制NHE-1（钠氢交换异构体1），其有助于恢复从缺血/再灌注损伤的心脏功能，并降低心肌梗死率，表明它们对心肌细胞具有保护作用。因此，本发明的呋喃羰基胍衍生物可以有效地用于预防和治疗心肌梗死，心律失常，心绞痛等缺血性心脏病，也是应用于再灌注治疗的心脏保护剂的有希望的候选物，包括溶栓剂或心脏手术，包括冠状动脉旁路移植术，经皮腔内冠状动脉血管成形术等

6. 发明授权

US07279497B2 Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them 有权
标题翻译：用包括咪唑的仲胺取代的苯并吡喃衍生物，其制备方法和含有它们的药物组合物
公开(公告)号：US07279497B2
公开(公告)日：2007-10-09
申请号：US10523015
申请日：2003-07-30
申请人： Kyu Yang Yi , Sun Kyung Lee , Sung-Eun Yoo , Jee Hee Suh , Nak Jeong Kim , Sun Kyung Hwang , Byung-Ho Lee , Ho Won Seo , Chong Ock Lee , Sang-Un Choi
发明人： Kyu Yang Yi , Sun Kyung Lee , Sung-Eun Yoo , Jee Hee Suh , Nak Jeong Kim , Sun Kyung Hwang , Byung-Ho Lee , Ho Won Seo , Chong Ock Lee , Sang-Un Choi
IPC分类号： A61K31/4164 , C07D233/54
CPC分类号： C07D405/12
摘要： The present invention relates to benzopyran derivatives substituted with secondary amines including imidazole, their preparation, and pharmaceutical compositions containing them. The present invention is pharmacologically useful for the treatment of cancer, rheumatoid arthritis, and diabetic retinopathies through anti-angiogenic properties, and also pharmacologically useful in the protection of heart and neuronal cells against ischemia-reperfusion injury or preserving organs.
摘要翻译：本发明涉及被仲胺包括咪唑取代的苯并吡喃衍生物，其制备方法和含有它们的药物组合物。本发明在药理学上可用于通过抗血管生成特性治疗癌症，类风湿性关节炎和糖尿病性视网膜病变，并且还可用于保护心脏和神经细胞免受缺血再灌注损伤或保存器官的药理作用。

7. 发明授权

US08279400B2 Super-resolution lithography apparatus and method based on multi light exposure method 有权
标题翻译：基于多光曝光方法的超分辨光刻设备及方法
公开(公告)号：US08279400B2
公开(公告)日：2012-10-02
申请号：US12403111
申请日：2009-03-12
申请人： Hee Su Park , Sun Kyung Lee , Jae Yong Lee , Sang-Kyung Choi , Dong-Hoon Lee
发明人： Hee Su Park , Sun Kyung Lee , Jae Yong Lee , Sang-Kyung Choi , Dong-Hoon Lee
IPC分类号： G03B27/42
CPC分类号： G03F7/70408 , G03F7/7005 , G03F7/70466 , G03F7/70575
摘要： Disclosed herein is a super-resolution lithography apparatus and method based on a multiple light exposure method. The super-resolution lithography apparatus comprises a photographic medium having energy levels of a first ground state, a second ground state, a first excited state, a second excited state and a quenching state; a first light source inducing energy level transition between the first ground state and the first excited state of the photographic medium; a second light source inducing energy level transition between the second ground state and the first excited state of the photographic medium; and a third light source inducing energy level transition between the second ground state and the second excited state of the photographic medium. Accordingly, the resolution of lithography can be improved simply by using a photographic medium having a simple structure and conventional laser beams and increasing the number of exposure steps. Furthermore, a multiple photon absorber that is difficult to obtain, a medium having a complicated energy level and a high-efficiency quantum optical light are unnecessary, and thus economic efficiency is improved.
摘要翻译：本文公开了一种基于多次曝光方法的超分辨率光刻设备和方法。超分辨光刻设备包括具有第一基态，第二基态，第一激发态，第二激发态和淬灭态的能级的照相介质; 在照相介质的第一基态和第一激发态之间引起能级转变的第一光源; 第二光源，在所述第二基态和所述照相介质的所述第一激发态之间引起能级转变; 以及在照相介质的第二基态和第二激发态之间引起能级跃迁的第三光源。因此，可以简单地通过使用具有简单结构和传统激光束的照相介质并增加曝光步骤的数量来改进光刻的分辨率。此外，难以获得难以获得的多光子吸收体，具有复杂的能级和高效量子光的介质，因而提高了经济效率。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式